Cite

3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes

MLA

Arnon Blum, et al. “3-Hydroxy-3-Methylglutaryl Coenzyme a (HMG-CoA) Reductase Inhibitors (Statins), Atherosclerosis and Coronary Syndromes.” Atherosclerosis, vol. 175, July 2004, pp. 1–5. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2003.12.024.



APA

Arnon Blum, Yonathan Hasin, & Claudia Simsolo. (2004). 3-Hydroxy-3-methylglutaryl coenzyme a (HMG-CoA) reductase inhibitors (statins), atherosclerosis and coronary syndromes. Atherosclerosis, 175, 1–5. https://doi.org/10.1016/j.atherosclerosis.2003.12.024



Chicago

Arnon Blum, Yonathan Hasin, and Claudia Simsolo. 2004. “3-Hydroxy-3-Methylglutaryl Coenzyme a (HMG-CoA) Reductase Inhibitors (Statins), Atherosclerosis and Coronary Syndromes.” Atherosclerosis 175 (July): 1–5. doi:10.1016/j.atherosclerosis.2003.12.024.